Why do life sciences deals fail? Insights from industry dealmakers
Dealmaking is a key driver of innovation and growth for life sciences companies. Regulation, complexity, scientific discovery and uncertainty are hallmarks of the sector, but can lead to higher-than-average attrition rates for deals.
This report, based on interviews with life sciences dealmaking veterans, looks at key risk factors for buyers and sellers in life sciences deals - and how to avoid them to increase the probability of deal success.
Please complete the form opposite to download the report.
STERLING TECHNOLOGY LTD.
4th Floor, Aldgate House 33 Aldgate High Street London EC3N 1AH